A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia

Clinical trial NCT01105598 · COMPLETED

Trial details

NCT number: NCT01105598
Sponsor: Esperion Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mild Dyslipidemia

Start date: 2010-04-20
Primary completion: 2010-10-02
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.